PETER RET: Open Payments
NPI 1649535162 · LIVONIA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$902 in 50 payments from 13 companies in 2025. Trend: 2023 $712 · 2024 $969 · 2025 $902
Food & beverage: $747Education: $155
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $283 |
| ABBVIE INC. | 18 | $220 |
| GENZYME CORPORATION | 3 | $92 |
| SANOFI-AVENTIS U.S. LLC | 1 | $72 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $54 |
| Botanix SB Inc | 2 | $39 |
| Novartis Pharmaceuticals Corporation | 1 | $35 |
| UCB, Inc. | 2 | $31 |
| KYOWA KIRIN, INC. | 1 | $20 |
| Amgen Inc. | 1 | $20 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, AYVAKIT, Winlevi, SOFDRA, Bimzelx, POTELIGEO.
Industry payments across MI — which companies pay providers there.
